Form 4: HealthStream Executive Vice President Michael Collier Reports Stock Transactions

Executive Vice President Michael Collier reports the vesting of restricted share units and subsequent stock transactions.

Summary

• On February 27, 2025, Michael Collier, Executive Vice President of HealthStream Inc., reported transactions involving HealthStream's common stock.
• 3,600 shares were acquired upon the vesting of restricted share units (RSUs) at a price of $0.
• 1,047 shares were withheld for payment of tax liability at a price of $32.37.
• Following these transactions, Collier directly owns 43,406 shares of HealthStream common stock.
• Collier also holds 12,023 restricted share units, which vest in installments between February 2026 and February 2030, contingent upon continued service and the achievement of certain performance criteria.
• The vesting schedule for the newly granted RSUs is as follows: 15% on February 27, 2026; 20% on February 27, 2027; 20% on February 27, 2028; 20% on February 27, 2029; and 25% on February 27, 2030.
• The performance criteria for the period January 1, 2024 through December 31, 2024 was achieved; therefore 20% of the awards vested on February 23, 2025.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of executive stock transactions. The vesting of RSUs suggests that performance targets were met, which is mildly positive. However, the document itself is neutral in tone.

Positives

• The vesting of RSUs indicates that performance criteria were met for the period January 1, 2024 through December 31, 2024.
• The grant of new RSUs aligns executive compensation with long-term company performance and retention.

Risks

• The value of the RSUs is contingent upon the future stock price of HealthStream.
• The vesting of future RSUs is dependent on continued service and the achievement of performance criteria, which are subject to change.

Future Outlook

Future vesting of RSUs is contingent upon continued service and the achievement of performance criteria established annually by the Compensation Committee.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are regularly monitored by investors for insights into management's confidence in the company's future prospects.

Comparison to Industry Standards

• RSU grants are a typical component of executive compensation packages in the healthcare technology industry, aligning executive incentives with shareholder value.
• Vesting schedules and performance criteria are generally designed to incentivize long-term growth and retention, similar to practices at companies like Cerner (now Oracle Health) and Allscripts Healthcare Solutions.

Stakeholder Impact

• Shareholders may view the vesting of RSUs as a positive sign, indicating that the company is achieving its performance goals.
• Employees may be motivated by the fact that executive compensation is tied to company performance.

Key Dates